Brainalyze
Brainalyze enables early dementia detection with a simple, rapid blood test. It uses MX-Raman, a proprietary platform that combines optical fingerprinting with interpretable AI to detect and differentiate dementias in about five minutes. The system requires no reagents or complex steps and is portable and scalable. Target customers include hospitals, clinics, and researchers for screening, triage, differential diagnosis, and clinical trial stratification. The approach aims to support a global dementia screening program and expand access to affordable, rapid diagnostics.
Brainalyze
Brainalyze enables early dementia detection with a simple, rapid blood test. It uses MX-Raman, a proprietary platform that combines optical fingerprinting with interpretable AI to detect and differentiate dementias in about five minutes. The system requires no reagents or complex steps and is portable and scalable. Target customers include hospitals, clinics, and researchers for screening, triage, differential diagnosis, and clinical trial stratification. The approach aims to support a global dementia screening program and expand access to affordable, rapid diagnostics.